Literature DB >> 24145040

Prognostic value of cell-free DNA in plasma of out-of-hospital cardiac arrest survivors at ICU admission and 24h post-admission.

Ivan Gornik1, Jasenka Wagner2, Vladimir Gašparović3, Davor Miličić4, Vesna Degoricija5, Boško Skorić4, Olga Gornik6, Gordan Lauc7.   

Abstract

Cell-free DNA has been associated with outcome in several acute conditions including two reports concerning the outcomes after cardiac arrest that found association of circulating DNA quantities at admission with mortality. The origins of cell-free DNA are primarily necrosis and apoptosis, which in cardiac arrest occur during ischaemia ("no-flow" and "low-flow" period), during reperfusion injury and as a consequence of post-arrest inflammatory response. Respecting the facts that significant cellular damage may occur during the post-arrest period, and that damage might be reduced by mild therapeutic hypothermia, we investigated the prognostic value of cell free DNA at ICU admission and 24h after admission. A prospective study was conducted in three university associated intensive care units and included patients resuscitated from non-traumatic out-of-hospital cardiac arrest. Patient data were collected in accordance with the Utstein protocol. Therapeutic hypothermia was performed according to ICU policies. Blood for cell-free DNA quantification was sampled at admission and at 24±1h after admission. Outcome measures were hospital morality and cerebral performance expressed with CPC scale at discharge. Inclusion criteria were met in 67 patients; 24-h mortality was 37.3% and hospital mortality was 71.6%. The following variables were associated with 24-h mortality in univariate analysis: asystole as the presenting rhythm, "no-flow" time, "low-flow" time and cell-free DNA at admission (median 0.081 in survivors vs. 0.160ng/μl in non-survivors; P=0.038). Multivariate analysis that included the above variables showed that no-flow time and low-flow time were independently associated with 24-h mortality. Hospital mortality was associated with the following factors: "low flow" time, coronary intervention, cell-free DNA at ICU admission and at 24h after admission (0.042 vs. 0.188ng/μl; P=0.048). ROC curve for cell-free DNA 24h post-admission showed sensitivity of 81.0% and specificity of 78.3% for the cut-off value of 0.115ng/μl. Multivariate analysis showed that "low-flow" time and cell-free DNA at 24h after ICU admission were independently associated with hospital mortality. Cell free DNA showed different dynamics in patients who were and who were not treated with mild therapeutic hypothermia: it decreased in treated patients and slightly increased in non-treated patients. Cell-free DNA quantity at ICU admission and 24h after admission is associated with hospital mortality. Further studies will need to additionally investigate possible practical use of this new laboratory marker in patients resuscitated from cardiac arrest.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24145040     DOI: 10.1016/j.resuscitation.2013.10.008

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  8 in total

1.  The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.

Authors:  Yikui Tian; Eric J Charles; Zhen Yan; Di Wu; Brent A French; Irving L Kron; Zequan Yang
Journal:  J Thorac Cardiovasc Surg       Date:  2018-10-05       Impact factor: 5.209

Review 2.  The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness.

Authors:  Kevin C Ma; Edward J Schenck; Maria A Pabon; Augustine M K Choi
Journal:  Am J Respir Crit Care Med       Date:  2018-02-01       Impact factor: 21.405

3.  Characterization of mitochondrial injury after cardiac arrest (COMICA).

Authors:  Michael W Donnino; Xiaowen Liu; Lars W Andersen; Jon C Rittenberger; Benjamin S Abella; David F Gaieski; Joseph P Ornato; Raúl J Gazmuri; Anne V Grossestreuer; Michael N Cocchi; Antonio Abbate; Amy Uber; John Clore; Mary Anne Peberdy; Clifton W Callaway
Journal:  Resuscitation       Date:  2017-01-23       Impact factor: 5.262

Review 4.  Prognostic value of circulating DNA levels in critically ill and trauma patients.

Authors:  Edison Moraes Rodrigues Filho; Nilo Ikuta; Daniel Simon; Andrea Pereira Regner
Journal:  Rev Bras Ter Intensiva       Date:  2014 Jul-Sep

5.  Comet assay in evaluating deoxyribonucleic acid damage after out-of-hospital cardiac arrest.

Authors:  Radka Hazuková; Martina Rezácová; Renata Köhlerová; Tomáš Tomek; Eva Cermáková; Jaromír Kocí; Miloslav Pleskot
Journal:  Anatol J Cardiol       Date:  2017-06-22       Impact factor: 1.596

Review 6.  Coagulofibrinolytic Changes in Patients with Post-cardiac Arrest Syndrome.

Authors:  Takeshi Wada
Journal:  Front Med (Lausanne)       Date:  2017-09-29

7.  Mitochondrial DNA Together with miR-142-3p in Plasma Can Predict Unfavorable Outcomes in Patients after Acute Myocardial Infarction.

Authors:  Teodora Barbalata; Alina I Scarlatescu; Gabriela M Sanda; Laura Toma; Camelia S Stancu; Maria Dorobantu; Miruna M Micheu; Anca V Sima; Loredan S Niculescu
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

8.  Cell-free DNA increase over first 48 hours in emergency intensive care unit predicts fatal outcome in patients with shock.

Authors:  Dun Ling Xia; Hong Zhang; Qing Li Luo; A Fang Zhang; Li Xin Zhu
Journal:  J Int Med Res       Date:  2016-09-27       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.